Back to results
US 10,519,454 B2Granted
Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGEN
AssigneeToolgen Incorporated
InventorsEun Ji Kim, Seok Joong Kim
Life of this patent
Estimating the term…
Abstract
The disclosure provided herewith relates to a Campylobacter jejuni CRISPR/CAS system-derived RGEN and a use thereof.
Claims13
A composition for genome editing of a target DNA sequence comprising:
- an effective amount of an isolated guide RNA comprising a first sequence forming a duplex with a complementary strand of the target DNA sequence and a second sequence interacting with a Cas protein that recognizes a proto-spacer-adjacent motif (PAM) sequence of NNNNRYAC (SEQ ID NO:
- 1) or a DNA encoding the isolated guide RNA, wherein the isolated guide RNA comprises a first region comprising the first sequence, and
- a second region comprising a stem-loop structure, wherein the stem-loop structure comprises a stem of 13-18 bp in length comprising a sequence of SEQ ID NO:
- 2 (5′-GUUUUAGUCCCUUGUG-3′) and a complementary sequence thereof, and
- a recombinant Cas protein that recognizes the PAM sequence of NNNNRYAC (SEQ ID NO:
- 1) or a nucleic acid encoding the recombinant Cas protein for performing genome editing of the target DNA sequence in a eukaryotic cell,
- wherein the target DNA sequence is derived from a genome of the eukaryotic cell, and
- wherein the target DNA sequence is adjacent to the PAM sequence of NNNNRYAC (SEQ ID NO:
- 1).
6 more elements
Dependencies are inferred from the claim text.